ATE354087T1 - Die verwendung der familie der rev-erb receptoren im screening - Google Patents
Die verwendung der familie der rev-erb receptoren im screeningInfo
- Publication number
- ATE354087T1 ATE354087T1 AT99928010T AT99928010T ATE354087T1 AT E354087 T1 ATE354087 T1 AT E354087T1 AT 99928010 T AT99928010 T AT 99928010T AT 99928010 T AT99928010 T AT 99928010T AT E354087 T1 ATE354087 T1 AT E354087T1
- Authority
- AT
- Austria
- Prior art keywords
- rev
- substances
- screening
- iii
- useful
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9808093A FR2780512B1 (fr) | 1998-06-25 | 1998-06-25 | Utilisation de recepteurs de la famille rev-erb pour le criblage de substances utiles dans le traitement des dysfonctionnements du metabolisme lipidique |
| PCT/EP1999/004286 WO1999067637A1 (en) | 1998-06-25 | 1999-06-21 | Use of rev-erb family of receptors in screening |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE354087T1 true ATE354087T1 (de) | 2007-03-15 |
Family
ID=9527876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99928010T ATE354087T1 (de) | 1998-06-25 | 1999-06-21 | Die verwendung der familie der rev-erb receptoren im screening |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7691628B1 (de) |
| EP (1) | EP1090292B1 (de) |
| JP (1) | JP2003524755A (de) |
| AT (1) | ATE354087T1 (de) |
| AU (1) | AU4515599A (de) |
| CA (1) | CA2336009C (de) |
| ES (1) | ES2283118T3 (de) |
| FR (1) | FR2780512B1 (de) |
| NZ (1) | NZ507935A (de) |
| TW (1) | TW577984B (de) |
| WO (1) | WO1999067637A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL151355A0 (en) * | 2000-03-03 | 2003-04-10 | Smithkline Beecham Biolog | Vaccine for the treatment of artherosclerosis |
| US6579686B2 (en) | 2000-03-23 | 2003-06-17 | Smithkline Beecham Corporation | Constitutive androstane receptor |
| FR2834996B1 (fr) * | 2002-01-18 | 2004-12-03 | Genfit S A | Methode d'identification de substances capables de moduler la differenciation adipocytaire |
| JP2005516605A (ja) * | 2002-02-01 | 2005-06-09 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | 心血管疾患を処置するための方法および組成物 |
| AU2003227071A1 (en) * | 2002-03-14 | 2003-09-22 | Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung | Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| AU2003274715A1 (en) * | 2002-06-10 | 2003-12-22 | Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung | L(2)44 dea, wunen-2, grapes, cg2221, cg1172, rutabaga, cg11940, facl involved in the regulation of energy homeostasis |
| JPWO2004053124A1 (ja) * | 2002-12-06 | 2006-04-13 | 塩野義製薬株式会社 | 糖尿病治療剤又は予防剤のスクリーニング方法 |
| EP1572227B1 (de) * | 2002-12-16 | 2012-02-15 | DeveloGen Aktiengesellschaft | Pik4cb involviert in der regulierung des energiestoffwechsels |
| AU2012314501B2 (en) | 2011-09-27 | 2017-02-16 | Genfit | Derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2222562A1 (en) * | 1995-06-07 | 1996-12-19 | Jeffrey N. Miner | Method for screening for receptor agonists and antagonists |
| US5906920A (en) * | 1995-08-29 | 1999-05-25 | The Salk Institute For Biological Studies | Methods for the detection of ligands for retinoid X receptors |
| DK0873295T3 (da) * | 1995-10-06 | 2003-07-14 | Ligand Pharm Inc | Dimer-selektive RXR-modulatorer og fremgangsmåder til deres anvendelse |
| CA2266543C (en) * | 1996-09-24 | 2003-12-09 | Cadus Pharmaceutical Corporation | Methods and compositions for identifying receptor effectors |
| WO1998052968A1 (en) * | 1997-05-21 | 1998-11-26 | The Salk Institute For Biological Studies | Method for identification of modified receptor ligands and methods of use therefor |
-
1998
- 1998-06-25 FR FR9808093A patent/FR2780512B1/fr not_active Expired - Fee Related
-
1999
- 1999-06-21 WO PCT/EP1999/004286 patent/WO1999067637A1/en active IP Right Grant
- 1999-06-21 JP JP2000556244A patent/JP2003524755A/ja active Pending
- 1999-06-21 AT AT99928010T patent/ATE354087T1/de not_active IP Right Cessation
- 1999-06-21 CA CA002336009A patent/CA2336009C/en not_active Expired - Fee Related
- 1999-06-21 NZ NZ507935A patent/NZ507935A/en not_active IP Right Cessation
- 1999-06-21 AU AU45155/99A patent/AU4515599A/en not_active Abandoned
- 1999-06-21 EP EP99928010A patent/EP1090292B1/de not_active Expired - Lifetime
- 1999-06-21 ES ES99928010T patent/ES2283118T3/es not_active Expired - Lifetime
- 1999-06-21 US US09/720,037 patent/US7691628B1/en not_active Expired - Fee Related
- 1999-06-23 TW TW088110571A patent/TW577984B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2283118T3 (es) | 2007-10-16 |
| US7691628B1 (en) | 2010-04-06 |
| EP1090292A1 (de) | 2001-04-11 |
| NZ507935A (en) | 2003-10-31 |
| EP1090292B1 (de) | 2007-02-14 |
| WO1999067637A1 (en) | 1999-12-29 |
| AU4515599A (en) | 2000-01-10 |
| FR2780512B1 (fr) | 2003-10-17 |
| JP2003524755A (ja) | 2003-08-19 |
| TW577984B (en) | 2004-03-01 |
| CA2336009A1 (en) | 1999-12-29 |
| CA2336009C (en) | 2009-02-10 |
| FR2780512A1 (fr) | 1999-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE354087T1 (de) | Die verwendung der familie der rev-erb receptoren im screening | |
| PT1054887E (pt) | Derivados biciclicos de piridina e pirimidina como antagonistas de receptores no neuropeptido y | |
| TR199800091T1 (xx) | Ba����kl�k hastal�klar�n�n tedavisi i�in terap�tik maddeler olarak kullan�lan ��z�nebilir lenfotoksin-� resept�rleri ve anti-lenfotoksin resept�r� ve ligand� antikorlar�. | |
| EP1590336A4 (de) | Substituierte pyrazole, zusammensetzungen,die solche verbindungen enthalten, und anwendungsverfahren | |
| IL140622A0 (en) | Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| NO20010446L (no) | Substituert anilidforbindelser og metoder | |
| ES2144386T1 (es) | Ligando para el activador receptor de nf-kappa b, cuyo ligando es miembro de la superfamilia tnf. | |
| DK0914345T3 (da) | Antistoffer, som binder til monocyt-kemoattraktant-protein-1-receptor (MCP-1-receptor) (CCR2) | |
| SE9600648D0 (sv) | Receptorbimdande enhet | |
| ATE394121T1 (de) | Verwendung von antikörpern gegen das muc18- antigen | |
| ATE517125T1 (de) | ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN | |
| DE69725345D1 (de) | Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden | |
| WO2004093908A3 (en) | Compositions and methods for the therapy of inflammatory bowel disease | |
| GB2295317B (en) | Liquid composition containing ondansetron | |
| DE60012040D1 (de) | Trizyklische 1-benzylpyrazol-3-carbonsäurederivate als cannabinoidrezeptorantagonisten | |
| Narukawa et al. | Galangal pungent component, 1′-acetoxychavicol acetate, activates TRPA1 | |
| Kimura et al. | Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist | |
| Marchon et al. | Effects of moderate exercise on the biochemical, physiological, morphological and functional parameters of the aorta in the presence of estrogen deprivation and dyslipidemia: an experimental model | |
| MY134755A (en) | Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors | |
| Nickl et al. | Anti-inflammatory role of Gpnmb in adipose tissue of mice | |
| CA2207505A1 (en) | Neurological drug screens | |
| Proctor | Muscarinic receptors and salivary secretion | |
| DE60135158D1 (de) | Antagonisten des ige-rezeptors | |
| ATE233320T1 (de) | Antagonisten von humanem interleukin-6, welche zur bindung mit gp 130 unfähig sind und ihre verwendung in der herstellung von pharmazeutische zusammensetzungen | |
| Tee et al. | Effects of root extracts of Eurycoma longifolia jack on Corpus cavernosum of rat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |